{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:11:18Z","timestamp":1779264678130,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Members of an integrated pharmacy team (pharmacists and pharmacy technicians) have roles that have been identified in the literature as part of the multi\u2010disciplinary cystic fibrosis (CF) care team. One role that has not specifically addressed is the administration of routine and recommended immunizations to people with CF (PwCF). According to care guidelines, PwCF of all ages should be provided all age\u2010appropriate and recommended immunizations. Pharmacists and pharmacy technicians can administer immunizations per state laws. The Primary Children's CF Center decided to implement a comprehensive pharmacy\u2010driven immunization care process model to impact immunization rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A 24\u2010month retrospective analysis was conducted with pediatric (\u226418 years) PwCF at the Primary Children's CF Center. The primary outcome measures were the percentage (%) of PwCF who received PPSV23, and\/or HPV, and\/or meningococcal conjugate vaccine (MCV) immunizations 1\u2010year post\u2010care process model implementation (October 1, 2021, to September 30, 2022) as compared to baseline values. The secondary outcome measures are the total number of immunizations, the number of each immunization provided, and the financial impact of pharmacy\u2010driven immunization care process model 1\u2010year post\u2010implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the 1\u2010year post\u2010care process model implementation (October 1, 2021, to September 30, 2022), a total of 523 immunizations were provided to 243 pediatric PwCF. The most frequent immunizations provided were PPSV23 (160\/523, 31%) and Coronavirus Disease 2019 (COVID\u201019) (154\/523, 29%). The baseline percentages of eligible PwCF of PPSV23, HPV, and MCV were 27% (58\/217), 43% (32\/74), and 24% (8\/34), respectively. The 1\u2010year post\u2010implementation percentages of PPSV23, HPV, and MCV were 99% (217\/218, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001), 91% (67\/74, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001), and 97% (33\/34, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001), respectively. For COVID\u201019 immunizations, 56% of eligible PwCF (181\/321) have received their first dose. Of these 181 PwCF, 70% (126\/181) have received at least one dose of their primary series or booster during the 1\u2010year post\u2010implementation period. The rate of those PwCF who have received at least one dose of a COVID\u201019 immunization from the age of 6 months to 4 years, 5\u201311 years, and 12\u201318 years, was 37% (30\/82), 60% (78\/129), and 66% (73\/110), respectively. For the financial impact generated during the 1\u2010year immunization care process model post\u2010implementation period, 404 non\u2010VFC immunizations were given for an estimated profit of $11,930.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The implementation of a pharmacy\u2010driven immunization care process model is a way for integrated pharmacy teams to evolve with the CF center care model and have a role expansion in the care provided to PwCF.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ppul.26306","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:14:33Z","timestamp":1672895673000},"page":"1145-1151","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Implementation of a comprehensive pharmacy\u2010driven immunization care process model in a pediatric cystic fibrosis clinic"],"prefix":"10.1002","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6047-306X","authenticated-orcid":false,"given":"Jeffery T.","family":"Zobell","sequence":"first","affiliation":[{"name":"Department of Pharmacy Primary Children's Cystic Fibrosis Center Salt Lake City Utah USA"},{"name":"Department of Pharmacy Intermountain Primary Children's Hospital Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Primary Children's Cystic Fibrosis Center Salt Lake City Utah USA"},{"name":"Department of Pharmacy Intermountain Primary Children's Hospital Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Creelman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Intermountain Healthcare Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rilee","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Intermountain Healthcare Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bevan","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Intermountain Primary Children's Outpatient Pharmacy Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Primary Children's Cystic Fibrosis Center Salt Lake City Utah USA"},{"name":"Department of Pediatric Pulmonology University of Utah School of Medicine Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Ameel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Primary Children's Cystic Fibrosis Center Salt Lake City Utah USA"},{"name":"Department of Pediatric Pulmonology University of Utah School of Medicine Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Asfour","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Primary Children's Cystic Fibrosis Center Salt Lake City Utah USA"},{"name":"Department of Pediatric Pulmonology University of Utah School of Medicine Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3"},{"key":"e_1_2_9_3_1","unstructured":"Foundation CF. 2021 Cystic Fibrosis Foundation Patient Registry Highlights. Bethesda MD. 2022."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.12.002"},{"key":"e_1_2_9_5_1","unstructured":"Trust CF. Pharmacy Standards in Cystic Fibrosis Care. 2011."},{"key":"e_1_2_9_6_1","article-title":"Telehealth and CFTR modulators: accelerating innovative models of cystic fibrosis care","author":"Prickett MH","year":"2022","journal-title":"J Cyst Fibros"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25283"},{"issue":"1","key":"e_1_2_9_8_1","first-page":"S17","article-title":"The indispensable role of pharmacy services and medication therapy management in cystic fibrosis","volume":"57","author":"Grant JJ","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_9_9_1","unstructured":"Australia CF. Cystic Fibrosis Standards of Care Australia. 2008."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.1_suppl.1S"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.09.001"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1784"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.10.003"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/61.14.1490"},{"key":"e_1_2_9_15_1","unstructured":"https:\/\/www.immunize.org\/pharmacists"},{"key":"e_1_2_9_16_1","unstructured":"2022.https:\/\/www.socscistatistics.com\/tests\/mannwhitney\/"},{"key":"e_1_2_9_17_1","unstructured":"Where Do Americans Get Vaccines and How Much It Cost to Administer Them?2022.https:\/\/www.healthsystemtracker.org\/chart-collection\/where-do-americans-get-vaccines-and-how-much-does-it-cost-to-administer-them\/#Where%20adults%20receive%20flu%20vaccine %202018"},{"key":"e_1_2_9_18_1","unstructured":"2022.https:\/\/www.cms.gov\/medicare\/covid-19\/medicare-covid-19-vaccine-shot-payment"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.03.018"},{"key":"e_1_2_9_20_1","unstructured":"Public Health Indicator Based Information System (IBIS). 2022.https:\/\/ibis.health.utah.gov\/ibisph-view\/indicator\/important_facts\/ImmHPV.html"},{"key":"e_1_2_9_21_1","unstructured":"(DHHS) UDoHaHS.2022.https:\/\/coronavirus-dashboard.utah.gov\/vaccines.html"},{"key":"e_1_2_9_22_1","unstructured":"Updated July 26 2022. Accessed October 8 2022. 2022.\u00a0https:\/\/www.salary.com\/research\/salary\/benchmark\/pharmacist-salary"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.26306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.26306","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.26306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T20:44:21Z","timestamp":1692305061000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.26306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1002\/ppul.26306"],"URL":"https:\/\/doi.org\/10.1002\/ppul.26306","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"2022-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}